METHODS AND MATERIALS FOR REDUCING LIVER FIBROSIS
- 专利权人:
- Michael R. Charlton
- 发明人:
- Michael R. Charlton
- 申请号:
- US13643042
- 公开号:
- US20130202619A1
- 申请日:
- 2011.04.22
- 申请国别(地区):
- US
- 年份:
- 2013
- 代理人:
- 摘要:
- This document relates to methods and materials for treating diseases or disorders that are caused by or associated with lumican deposition (e.g., liver fibrosis). For example, methods and materials for reducing liver fibrosis by reducing lumican expression or activity within a mammal (e.g., a human) are provided.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- METHOD OF TREATING OR PREVENTING TISSUE DETERIORATION, INJURY OR DAMAGE DUE TO A NEURO-, MUSCULAR- OR NEURO-MUSCULAR-DEGENERATIVE DISEASE, OR RESTORE TISSUE ADVERSELY AFFECTED BY SAID DISEASE
- COMPOSITIONS ET METHODES D'ACTIVATION DE SYNTHESE DE PROTEINES ET DE DESACTIVATION DE PROCESSUS CATABOLIQUES DANS LE MUSCLE SQUELETTIQUE
- COMPOSITION POUR PRÉVENIR OU TRAITER DES MALADIES LIÉES AUX MUSCLES, CONTENANT UN EXTRAIT D'ANGELICA KEISKEI OU UN COMPOSÉ ISOLÉ À PARTIR DE CELUI-CI, ET SON UTILISATION
- N-ACETYL MANNOSAMINE OU DERIVES DE CELUI-CI POUR LE TRAITEMENT D'UNE MALADIE RENALE CHEZ UN MAMMIFERE
- METHOD OF NEUROMUSCULAR RELAXATION OF FACIAL MUSCLES